Why hospital biobanks should supply biotechs

Photo by Martin Lopez from Pexels

When it comes to using biospecimens for research, the saying “garbage in, garbage out” applies (Compton, 2018). This maxim has been a driving force in biospecimen science: a field in which the focus is pre-analytical factors affecting biospecimen quality. It has also been a driving force in the professionalization of biobanking. As a result, the biobanking domain emphasizes best practices, quality standards, education, certification, accreditation, improved equipment, equipment monitoring and automation.

There is a consensus that biospecimen collection for research requires specialized units. These units, called biobanks or biorepositories, are important for ethical and scientific reasons. They are important for protecting patient interests through data protection and informed consent. They are also important for providing researchers with high-quality, reliable biospecimens…

Read more
  • 0

What’s driving the natural language processing revolution in pharma and life sciences

Image courtesy of Pixabay

Pharmaceutical and life sciences companies are faced with a constant stream of new data flowing into often siloed information systems. About 80% of that information exists in unstructured text that is difficult to extract and use, despite its paramount importance in driving clinical and commercial outcomes.

As a result, these organizations find themselves increasingly overwhelmed with volumes of inaccessible data. At the same time, researchers and data scientists lack effective search tools to find the right information in this “big data” tsunami, causing them to miss opportunities to enhance patient safety, improve clinical trial design, identify previously undetected biomarkers and better understand the voice of the customer.

To overcome the limitations of time-consuming, manual searches through mountains of data, pharma and life sciences companies are looking to artificial…

Read more
  • 0